TrademarkDir
DEBIO SPHERE
LIVE

Serial Number

79368652

Owner

Debiopharm International SA

Attorney

Duane M. Byers

Filing Date

Jan 16, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

DEBIO SPHERE Trademark

Serial Number: 79368652 • Registration: 7953910

DEBIO SPHERE is a trademark filed by Debiopharm International SA on January 16, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Debiopharm International SA (17 trademarks)

Forum "après-demain"
Lausanne CH1002 , CH

Entity Type: 99

Après-Demain SA

Forum "après-demain",

Entity Type: 33

Trademark Details

Filing Date

January 16, 2023

Registration Date

September 23, 2025

Published for Opposition

August 5, 2025

Goods & Services

Implantable devices, namely, drug delivery ports for the subcutaneous release of medicated substances

Pharmaceutical products and substances, namely, poly-lactic-co-glycolic acid (PLGA) formulations

Filing History

GENERIC MADRID TRANSACTION SENT TO IB
Mar 30, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 30, 2026 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 23, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 23, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 23, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 5, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 30, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 9, 2025 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
May 9, 2025 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
May 9, 2025 GNCF
ACTION CONTINUING A FINAL - COMPLETED
May 9, 2025 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 30, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 30, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 30, 2025 ERFR
CHANGE OF OWNER RECEIVED FROM IB
Mar 21, 2025 CHLD
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 30, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 30, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 30, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2024 CRFA
ASSIGNED TO LIE
Oct 23, 2024 ALIE
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 19, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 2, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 2, 2024 OPNR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 16, 2024 TROA
PETITION TO REVIVE-GRANTED
Jul 16, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Jul 16, 2024 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 16, 2024 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 16, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 16, 2024 ABN2
REFUSAL PROCESSED BY IB
Nov 13, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 25, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 25, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 18, 2023 RFCR
NON-FINAL ACTION WRITTEN
Oct 17, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 12, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 9, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 4, 2023 REPR

Related Trademarks

More from this Owner

TRIPTODUR CARE

TRIPTODUR CARE

TRIPTODUR CARE

TRIPTODUR CARE

LIBELULA

LIBELULA

LIBELULA

LIBELULA

LIBELULA

LIBELULA

FIBROTRAP

FIBROTRAP